BCACP/BCGP Clinical Session — From Evidence to Action: UTI Updates in Ambulatory Care and Older Adults

This session will provide an up to date, evidence-based overview of the latest guideline recommendations for urinary tract infection (UTI) management, including updates from the American Urological Association (AUA) Recurrent UTI Guideline and the 2025 Infectious Diseases Society of America (IDSA) Complicated UTI Guideline. Designed for BCACP and BCGP pharmacists and other advanced practice clinicians, the session focuses on translating current guidance into practical clinical decision making across ambulatory, geriatric, and team-based care settings.

This activity is approved for Board Certified Ambulatory Care Pharmacist (BCACP) and Board Certified Geriatric Pharmacist (BCGP) recertification credit.

The BCACP and BCGP Clinical Sessions are part of the professional development program for the recertification of board-certified Ambulatory Care or Geriatric pharmacists by the Board of Pharmacy Specialties and jointly provided by ACCP and the American Society of Health-System Pharmacists (ASHP). In order to earn the BCACP, BCGP recertification credit, participants must attend the session, claim the continuing pharmacy education credit, and pass the associated posttest.  Access to the Clinical Sessions posttests will be available on December 16, 2026, at www.accp.com/myaccount to anyone who has purchased access to the BCACP/BCGP posttests. For participants who have not purchased access to the posttests, access can be purchased until 12:00 p.m. on Tuesday, October 20, at the ACCP Registration Desk. The deadline to submit posttests for these sessions will be December 14, 2027.  

Speaker: Danielle Fixen, Pharm.D., BCGP University of Colorado Skaggs School of Pharmacy and Pharmaceutical Science   View Biography